Alnylam Pharmaceuticals · 1 week ago
Scientist, Process Sciences
Cambridge, MA
Full-time
Onsite
Mid Level
$114K/yr - $154K/yrAlnylam Pharmaceuticals is a leader in RNAi therapeutics, committed to innovative science and breakthrough thinking. The Scientist, Process Sciences will be responsible for the development, characterization, and scale-up of biocatalytic processes, collaborating with various teams to ensure successful manufacturing of oligonucleotide drug candidates.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Contribute to process development, optimization, and scale-up of biocatalytic processes
Support the process and product characterization of small molecules and oligonucleotide APIs
Contribute to the management and optimization of in-house and contract manufacturing processes
Author and review technical protocols and development reports in support of manufacturing and process characterization activities
Author, edit, and review manufacturing documentation according to regulatory and procedural guidelines
Work closely with analytical development, manufacturing, QA, QC and CMO/CRO on the process transfer and process optimization
Contribute to strategic technical discussions and presenting progress at internal and external scientific meetings
Qualification
Required
Ph.D. in chemistry, chemical engineering, or biochemical engineering
Process research and development experience in applied biocatalysis
Demonstrated proficiency in the design and development of practical processes for manufacture of small molecules and oligonucleotides
Hands-on experience in process development and analytical methods for process and product characterization
Excellent organizational and communication skills
Demonstrated strong operational execution and problem-solving skills
Desire to work in a fast-paced, deadline-driven environment
Benefits
Medical, dental, and vision coverage
Life and disability insurance
Lifestyle reimbursement program
Flexible spending and health savings accounts
401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Founded in 2002
1001-5000 employees
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
Clinical Trials Arena
2026-01-16
Longevity.Technology
2026-01-14
2026-01-13
Company data provided by crunchbase